Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial
Publication date: Available online 27 January 2021Source: The Lancet Respiratory MedicineAuthor(s): Dean A Fennell, Amy King, Seid Mohammed, Amy Branson, Cassandra Brookes, Liz Darlison, Alan G Dawson, Aarti Gaba, Margaret Hutka, Bruno Morgan, Adrian Nicholson, Cathy Richards, Peter Wells-Jordan, Gavin James Murphy, Anne Thomas, Dean Anthony Fennell, Amy King, Seid Mohammed, Amy Branson, Cassandra Brooks
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research
More News: Asbestosis | Clinical Trials | Jordan Health | Mesothelioma | Middle East Health | Respiratory Medicine